Global Hypersomnia Drug Market Growth (Status and Outlook) 2023-2029

March 2023 | 101 pages | ID: G6DAA0AAC9B4EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Hypersomnia indicates frequent and excessive daytime sleepiness. It becomes necessary for patients suffering from hypersomnia to take short naps in-between the day time and sleep more than 10 hours at night. However, the naps do not provide any relief. Also, patients may feel disoriented and can have difficulty in moving. Due to hypersomnia patients may have restlessness, loss of appetite hallucinations and slow speech.

LPI (LP Information)' newest research report, the “Hypersomnia Drug Industry Forecast” looks at past sales and reviews total world Hypersomnia Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Hypersomnia Drug sales for 2023 through 2029. With Hypersomnia Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hypersomnia Drug industry.

This Insight Report provides a comprehensive analysis of the global Hypersomnia Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hypersomnia Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hypersomnia Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hypersomnia Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hypersomnia Drug.

The global Hypersomnia Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Hypersomnia Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Hypersomnia Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Hypersomnia Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Hypersomnia Drug players cover Teva, Jazz Pharmaceuticals, BIOPROJET, AVADEL PHARMACEUTICALS, GlaxoSmithKline, Pfizer, Theranexus, Fisher & Paykel Healthcare and Drive Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Hypersomnia Drug market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Provigil
• Xyrem
• Others

Segmentation by application

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Teva
• Jazz Pharmaceuticals
• BIOPROJET
• AVADEL PHARMACEUTICALS
• GlaxoSmithKline
• Pfizer
• Theranexus
• Fisher & Paykel Healthcare
• Drive Medical
• Merck

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Hypersomnia Drug Market Size 2018-2029
  2.1.2 Hypersomnia Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Hypersomnia Drug Segment by Type
  2.2.1 Provigil
  2.2.2 Xyrem
  2.2.3 Others
2.3 Hypersomnia Drug Market Size by Type
  2.3.1 Hypersomnia Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Hypersomnia Drug Market Size Market Share by Type (2018-2023)
2.4 Hypersomnia Drug Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Retail Pharmacies
  2.4.3 Online Pharmacies
2.5 Hypersomnia Drug Market Size by Application
  2.5.1 Hypersomnia Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Hypersomnia Drug Market Size Market Share by Application (2018-2023)

3 HYPERSOMNIA DRUG MARKET SIZE BY PLAYER

3.1 Hypersomnia Drug Market Size Market Share by Players
  3.1.1 Global Hypersomnia Drug Revenue by Players (2018-2023)
  3.1.2 Global Hypersomnia Drug Revenue Market Share by Players (2018-2023)
3.2 Global Hypersomnia Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HYPERSOMNIA DRUG BY REGIONS

4.1 Hypersomnia Drug Market Size by Regions (2018-2023)
4.2 Americas Hypersomnia Drug Market Size Growth (2018-2023)
4.3 APAC Hypersomnia Drug Market Size Growth (2018-2023)
4.4 Europe Hypersomnia Drug Market Size Growth (2018-2023)
4.5 Middle East & Africa Hypersomnia Drug Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Hypersomnia Drug Market Size by Country (2018-2023)
5.2 Americas Hypersomnia Drug Market Size by Type (2018-2023)
5.3 Americas Hypersomnia Drug Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Hypersomnia Drug Market Size by Region (2018-2023)
6.2 APAC Hypersomnia Drug Market Size by Type (2018-2023)
6.3 APAC Hypersomnia Drug Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Hypersomnia Drug by Country (2018-2023)
7.2 Europe Hypersomnia Drug Market Size by Type (2018-2023)
7.3 Europe Hypersomnia Drug Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Hypersomnia Drug by Region (2018-2023)
8.2 Middle East & Africa Hypersomnia Drug Market Size by Type (2018-2023)
8.3 Middle East & Africa Hypersomnia Drug Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL HYPERSOMNIA DRUG MARKET FORECAST

10.1 Global Hypersomnia Drug Forecast by Regions (2024-2029)
  10.1.1 Global Hypersomnia Drug Forecast by Regions (2024-2029)
  10.1.2 Americas Hypersomnia Drug Forecast
  10.1.3 APAC Hypersomnia Drug Forecast
  10.1.4 Europe Hypersomnia Drug Forecast
  10.1.5 Middle East & Africa Hypersomnia Drug Forecast
10.2 Americas Hypersomnia Drug Forecast by Country (2024-2029)
  10.2.1 United States Hypersomnia Drug Market Forecast
  10.2.2 Canada Hypersomnia Drug Market Forecast
  10.2.3 Mexico Hypersomnia Drug Market Forecast
  10.2.4 Brazil Hypersomnia Drug Market Forecast
10.3 APAC Hypersomnia Drug Forecast by Region (2024-2029)
  10.3.1 China Hypersomnia Drug Market Forecast
  10.3.2 Japan Hypersomnia Drug Market Forecast
  10.3.3 Korea Hypersomnia Drug Market Forecast
  10.3.4 Southeast Asia Hypersomnia Drug Market Forecast
  10.3.5 India Hypersomnia Drug Market Forecast
  10.3.6 Australia Hypersomnia Drug Market Forecast
10.4 Europe Hypersomnia Drug Forecast by Country (2024-2029)
  10.4.1 Germany Hypersomnia Drug Market Forecast
  10.4.2 France Hypersomnia Drug Market Forecast
  10.4.3 UK Hypersomnia Drug Market Forecast
  10.4.4 Italy Hypersomnia Drug Market Forecast
  10.4.5 Russia Hypersomnia Drug Market Forecast
10.5 Middle East & Africa Hypersomnia Drug Forecast by Region (2024-2029)
  10.5.1 Egypt Hypersomnia Drug Market Forecast
  10.5.2 South Africa Hypersomnia Drug Market Forecast
  10.5.3 Israel Hypersomnia Drug Market Forecast
  10.5.4 Turkey Hypersomnia Drug Market Forecast
  10.5.5 GCC Countries Hypersomnia Drug Market Forecast
10.6 Global Hypersomnia Drug Forecast by Type (2024-2029)
10.7 Global Hypersomnia Drug Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Teva
  11.1.1 Teva Company Information
  11.1.2 Teva Hypersomnia Drug Product Offered
  11.1.3 Teva Hypersomnia Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Teva Main Business Overview
  11.1.5 Teva Latest Developments
11.2 Jazz Pharmaceuticals
  11.2.1 Jazz Pharmaceuticals Company Information
  11.2.2 Jazz Pharmaceuticals Hypersomnia Drug Product Offered
  11.2.3 Jazz Pharmaceuticals Hypersomnia Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Jazz Pharmaceuticals Main Business Overview
  11.2.5 Jazz Pharmaceuticals Latest Developments
11.3 BIOPROJET
  11.3.1 BIOPROJET Company Information
  11.3.2 BIOPROJET Hypersomnia Drug Product Offered
  11.3.3 BIOPROJET Hypersomnia Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 BIOPROJET Main Business Overview
  11.3.5 BIOPROJET Latest Developments
11.4 AVADEL PHARMACEUTICALS
  11.4.1 AVADEL PHARMACEUTICALS Company Information
  11.4.2 AVADEL PHARMACEUTICALS Hypersomnia Drug Product Offered
  11.4.3 AVADEL PHARMACEUTICALS Hypersomnia Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 AVADEL PHARMACEUTICALS Main Business Overview
  11.4.5 AVADEL PHARMACEUTICALS Latest Developments
11.5 GlaxoSmithKline
  11.5.1 GlaxoSmithKline Company Information
  11.5.2 GlaxoSmithKline Hypersomnia Drug Product Offered
  11.5.3 GlaxoSmithKline Hypersomnia Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 GlaxoSmithKline Main Business Overview
  11.5.5 GlaxoSmithKline Latest Developments
11.6 Pfizer
  11.6.1 Pfizer Company Information
  11.6.2 Pfizer Hypersomnia Drug Product Offered
  11.6.3 Pfizer Hypersomnia Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Pfizer Main Business Overview
  11.6.5 Pfizer Latest Developments
11.7 Theranexus
  11.7.1 Theranexus Company Information
  11.7.2 Theranexus Hypersomnia Drug Product Offered
  11.7.3 Theranexus Hypersomnia Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Theranexus Main Business Overview
  11.7.5 Theranexus Latest Developments
11.8 Fisher & Paykel Healthcare
  11.8.1 Fisher & Paykel Healthcare Company Information
  11.8.2 Fisher & Paykel Healthcare Hypersomnia Drug Product Offered
  11.8.3 Fisher & Paykel Healthcare Hypersomnia Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Fisher & Paykel Healthcare Main Business Overview
  11.8.5 Fisher & Paykel Healthcare Latest Developments
11.9 Drive Medical
  11.9.1 Drive Medical Company Information
  11.9.2 Drive Medical Hypersomnia Drug Product Offered
  11.9.3 Drive Medical Hypersomnia Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Drive Medical Main Business Overview
  11.9.5 Drive Medical Latest Developments
11.10 Merck
  11.10.1 Merck Company Information
  11.10.2 Merck Hypersomnia Drug Product Offered
  11.10.3 Merck Hypersomnia Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 Merck Main Business Overview
  11.10.5 Merck Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Hypersomnia Drug Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Provigil
Table 3. Major Players of Xyrem
Table 4. Major Players of Others
Table 5. Hypersomnia Drug Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Hypersomnia Drug Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Hypersomnia Drug Market Size Market Share by Type (2018-2023)
Table 8. Hypersomnia Drug Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Hypersomnia Drug Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Hypersomnia Drug Market Size Market Share by Application (2018-2023)
Table 11. Global Hypersomnia Drug Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Hypersomnia Drug Revenue Market Share by Player (2018-2023)
Table 13. Hypersomnia Drug Key Players Head office and Products Offered
Table 14. Hypersomnia Drug Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Hypersomnia Drug Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Hypersomnia Drug Market Size Market Share by Regions (2018-2023)
Table 19. Global Hypersomnia Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Hypersomnia Drug Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Hypersomnia Drug Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Hypersomnia Drug Market Size Market Share by Country (2018-2023)
Table 23. Americas Hypersomnia Drug Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Hypersomnia Drug Market Size Market Share by Type (2018-2023)
Table 25. Americas Hypersomnia Drug Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Hypersomnia Drug Market Size Market Share by Application (2018-2023)
Table 27. APAC Hypersomnia Drug Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Hypersomnia Drug Market Size Market Share by Region (2018-2023)
Table 29. APAC Hypersomnia Drug Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Hypersomnia Drug Market Size Market Share by Type (2018-2023)
Table 31. APAC Hypersomnia Drug Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Hypersomnia Drug Market Size Market Share by Application (2018-2023)
Table 33. Europe Hypersomnia Drug Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Hypersomnia Drug Market Size Market Share by Country (2018-2023)
Table 35. Europe Hypersomnia Drug Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Hypersomnia Drug Market Size Market Share by Type (2018-2023)
Table 37. Europe Hypersomnia Drug Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Hypersomnia Drug Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Hypersomnia Drug Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Hypersomnia Drug Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Hypersomnia Drug Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Hypersomnia Drug Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Hypersomnia Drug Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Hypersomnia Drug Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Hypersomnia Drug
Table 46. Key Market Challenges & Risks of Hypersomnia Drug
Table 47. Key Industry Trends of Hypersomnia Drug
Table 48. Global Hypersomnia Drug Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Hypersomnia Drug Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Hypersomnia Drug Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Hypersomnia Drug Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Teva Details, Company Type, Hypersomnia Drug Area Served and Its Competitors
Table 53. Teva Hypersomnia Drug Product Offered
Table 54. Teva Hypersomnia Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Teva Main Business
Table 56. Teva Latest Developments
Table 57. Jazz Pharmaceuticals Details, Company Type, Hypersomnia Drug Area Served and Its Competitors
Table 58. Jazz Pharmaceuticals Hypersomnia Drug Product Offered
Table 59. Jazz Pharmaceuticals Main Business
Table 60. Jazz Pharmaceuticals Hypersomnia Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Jazz Pharmaceuticals Latest Developments
Table 62. BIOPROJET Details, Company Type, Hypersomnia Drug Area Served and Its Competitors
Table 63. BIOPROJET Hypersomnia Drug Product Offered
Table 64. BIOPROJET Main Business
Table 65. BIOPROJET Hypersomnia Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. BIOPROJET Latest Developments
Table 67. AVADEL PHARMACEUTICALS Details, Company Type, Hypersomnia Drug Area Served and Its Competitors
Table 68. AVADEL PHARMACEUTICALS Hypersomnia Drug Product Offered
Table 69. AVADEL PHARMACEUTICALS Main Business
Table 70. AVADEL PHARMACEUTICALS Hypersomnia Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. AVADEL PHARMACEUTICALS Latest Developments
Table 72. GlaxoSmithKline Details, Company Type, Hypersomnia Drug Area Served and Its Competitors
Table 73. GlaxoSmithKline Hypersomnia Drug Product Offered
Table 74. GlaxoSmithKline Main Business
Table 75. GlaxoSmithKline Hypersomnia Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. GlaxoSmithKline Latest Developments
Table 77. Pfizer Details, Company Type, Hypersomnia Drug Area Served and Its Competitors
Table 78. Pfizer Hypersomnia Drug Product Offered
Table 79. Pfizer Main Business
Table 80. Pfizer Hypersomnia Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Pfizer Latest Developments
Table 82. Theranexus Details, Company Type, Hypersomnia Drug Area Served and Its Competitors
Table 83. Theranexus Hypersomnia Drug Product Offered
Table 84. Theranexus Main Business
Table 85. Theranexus Hypersomnia Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Theranexus Latest Developments
Table 87. Fisher & Paykel Healthcare Details, Company Type, Hypersomnia Drug Area Served and Its Competitors
Table 88. Fisher & Paykel Healthcare Hypersomnia Drug Product Offered
Table 89. Fisher & Paykel Healthcare Main Business
Table 90. Fisher & Paykel Healthcare Hypersomnia Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Fisher & Paykel Healthcare Latest Developments
Table 92. Drive Medical Details, Company Type, Hypersomnia Drug Area Served and Its Competitors
Table 93. Drive Medical Hypersomnia Drug Product Offered
Table 94. Drive Medical Main Business
Table 95. Drive Medical Hypersomnia Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Drive Medical Latest Developments
Table 97. Merck Details, Company Type, Hypersomnia Drug Area Served and Its Competitors
Table 98. Merck Hypersomnia Drug Product Offered
Table 99. Merck Main Business
Table 100. Merck Hypersomnia Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Merck Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Hypersomnia Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hypersomnia Drug Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Hypersomnia Drug Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Hypersomnia Drug Sales Market Share by Country/Region (2022)
Figure 8. Hypersomnia Drug Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Hypersomnia Drug Market Size Market Share by Type in 2022
Figure 10. Hypersomnia Drug in Hospital Pharmacies
Figure 11. Global Hypersomnia Drug Market: Hospital Pharmacies (2018-2023) & ($ Millions)
Figure 12. Hypersomnia Drug in Retail Pharmacies
Figure 13. Global Hypersomnia Drug Market: Retail Pharmacies (2018-2023) & ($ Millions)
Figure 14. Hypersomnia Drug in Online Pharmacies
Figure 15. Global Hypersomnia Drug Market: Online Pharmacies (2018-2023) & ($ Millions)
Figure 16. Global Hypersomnia Drug Market Size Market Share by Application in 2022
Figure 17. Global Hypersomnia Drug Revenue Market Share by Player in 2022
Figure 18. Global Hypersomnia Drug Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Hypersomnia Drug Market Size 2018-2023 ($ Millions)
Figure 20. APAC Hypersomnia Drug Market Size 2018-2023 ($ Millions)
Figure 21. Europe Hypersomnia Drug Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Hypersomnia Drug Market Size 2018-2023 ($ Millions)
Figure 23. Americas Hypersomnia Drug Value Market Share by Country in 2022
Figure 24. United States Hypersomnia Drug Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Hypersomnia Drug Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Hypersomnia Drug Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Hypersomnia Drug Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Hypersomnia Drug Market Size Market Share by Region in 2022
Figure 29. APAC Hypersomnia Drug Market Size Market Share by Type in 2022
Figure 30. APAC Hypersomnia Drug Market Size Market Share by Application in 2022
Figure 31. China Hypersomnia Drug Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Hypersomnia Drug Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Hypersomnia Drug Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Hypersomnia Drug Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Hypersomnia Drug Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Hypersomnia Drug Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Hypersomnia Drug Market Size Market Share by Country in 2022
Figure 38. Europe Hypersomnia Drug Market Size Market Share by Type (2018-2023)
Figure 39. Europe Hypersomnia Drug Market Size Market Share by Application (2018-2023)
Figure 40. Germany Hypersomnia Drug Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Hypersomnia Drug Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Hypersomnia Drug Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Hypersomnia Drug Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Hypersomnia Drug Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Hypersomnia Drug Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Hypersomnia Drug Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Hypersomnia Drug Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Hypersomnia Drug Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Hypersomnia Drug Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Hypersomnia Drug Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Hypersomnia Drug Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Hypersomnia Drug Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Hypersomnia Drug Market Size 2024-2029 ($ Millions)
Figure 54. APAC Hypersomnia Drug Market Size 2024-2029 ($ Millions)
Figure 55. Europe Hypersomnia Drug Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Hypersomnia Drug Market Size 2024-2029 ($ Millions)
Figure 57. United States Hypersomnia Drug Market Size 2024-2029 ($ Millions)
Figure 58. Canada Hypersomnia Drug Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Hypersomnia Drug Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Hypersomnia Drug Market Size 2024-2029 ($ Millions)
Figure 61. China Hypersomnia Drug Market Size 2024-2029 ($ Millions)
Figure 62. Japan Hypersomnia Drug Market Size 2024-2029 ($ Millions)
Figure 63. Korea Hypersomnia Drug Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Hypersomnia Drug Market Size 2024-2029 ($ Millions)
Figure 65. India Hypersomnia Drug Market Size 2024-2029 ($ Millions)
Figure 66. Australia Hypersomnia Drug Market Size 2024-2029 ($ Millions)
Figure 67. Germany Hypersomnia Drug Market Size 2024-2029 ($ Millions)
Figure 68. France Hypersomnia Drug Market Size 2024-2029 ($ Millions)
Figure 69. UK Hypersomnia Drug Market Size 2024-2029 ($ Millions)
Figure 70. Italy Hypersomnia Drug Market Size 2024-2029 ($ Millions)
Figure 71. Russia Hypersomnia Drug Market Size 2024-2029 ($ Millions)
Figure 72. Spain Hypersomnia Drug Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Hypersomnia Drug Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Hypersomnia Drug Market Size 2024-2029 ($ Millions)
Figure 75. Israel Hypersomnia Drug Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Hypersomnia Drug Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Hypersomnia Drug Market Size 2024-2029 ($ Millions)
Figure 78. Global Hypersomnia Drug Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Hypersomnia Drug Market Size Market Share Forecast by Application (2024-2029)